Jessica Garlewicz, Digital Managing Editor

AAD Conference Preview: Cutaneous Squamous Cell Carcinoma Updates

04/25/2023

In this feature interview, Dr Lilia Correa previewed her session, “Cutaneous Squamous Cell Carcinoma Update,” before its presentation at the 2023 AAD Annual Meeting.

In this feature interview, Dr...

04/25/2023

Autoimmune

News

Periodontal Inflammation Linked to Psoriasis and Psoriatic Arthritis

04/20/2023

Jessica Garlewicz, Digital Managing Editor

Researchers aimed to examine the link between dental and periodontal health parameters in patients with psoriasis and/or psoriatic arthritis.

Researchers aimed to examine the...

04/20/2023

Dermatology

News

Bidirectional Associations Between Migraine and Psoriasis

04/20/2023

Jessica Garlewicz, Digital Managing Editor

Researchers aimed to evaluate the association between psoriasis and migraine by analyzing MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials.

Researchers aimed to evaluate...

04/20/2023

The Dermatologist

Conference Coverage

Nail Psoriasis: Treatment Insights

04/06/2023

Jessica Garlewicz, Digital Managing Editor

During his session, “Management of Nail Psoriasis,” presented at the 2023 AAD Annual Meeting, Bertrand Richert, MD, PhD, FAAD, discussed nail treatment for psoriasis.

During his session, “Management...

04/06/2023

The Dermatologist

Q&As

New Technology on the Horizon: Nonthermal Plasma

04/05/2023

Jessica Garlewicz, Digital Managing Editor

In this exclusive interview with The Dermatologist, Dr Peter Friedman introduces nonthermal plasma and shares insights into how this new technology is being reviewed and implemented in practice.

In this exclusive interview with...

04/05/2023

The Dermatologist

FDA Alerts

New Drug Application Accepted by the Food and Drug Administration for Berdazimer Gel 10.3%

03/30/2023

Jessica Garlewicz, Digital Managing Editor

The FDA recently announced its acceptance of a new drug application for Novan’s berdazimer gel 10.3% for the treatment of molluscum contagiosum.

The FDA recently announced its...

03/30/2023

The Dermatologist

Cancer Therapies and Nail Toxicities

03/22/2023

Jessica Garlewicz, Digital Managing Editor

On the fourth day of the 2023 AAD Annual Meeting, Beth McLellan, MD, FAAD, presented the nail changes related to cancer therapies during her session, “Management of Nail Toxicities Due to Cancer Therapy.”

On the fourth day of the 2023...

03/22/2023

Dermatology

COVID-19 and Melanoma in Veterans Care

03/22/2023

Jessica Garlewicz, Digital Managing Editor

During her session, “Melanoma in Veterans and the COVID-19 Pandemic,” presented on the fourth day of the 2023 AAD Annual Meeting, Rebecca Hartman, MD, MPH, shared insights into tailoring melanoma care for veterans.

During her session, “Melanoma in...

03/22/2023

Dermatology

Patient Attitudes Improved Following Use of Artificial Intelligence in Scalp Alopecia

03/19/2023

Jessica Garlewicz, Digital Managing Editor

Researchers aimed to examine patient attitudes regarding their alopecia treatment when under the effects of artificial intelligence-based hair counts and microphotography.

Researchers aimed to examine...

03/19/2023

The Dermatologist

Alopecia Areata Clinical Trials See Decrease in Hispanic and Black Participation

03/19/2023

Jessica Garlewicz, Digital Managing Editor

According to a poster presented at the 2023 AAD Annual Meeting, Hispanic and Black patients tend to be underrepresented in alopecia areata clinical trials.

According to a poster presented...

03/19/2023

The Dermatologist